More on GenMark Q2 results

GenMark Diagnostics (GNMK +0.3%) Q2 results: Revenues: $6.6M (+25.7%); Operating Loss: ($11.3M) (-39.3%); Net Loss: ($11.2M) (-39.8%); Loss Per Share: ($0.27) (-8.0%); Quick Assets: $89.4M (-15.3%); Cash Burn (1H): ($13.5M) (-1.4%).

No financial guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs